← 產業報告目錄

Lyophilization Services for Biopharmaceuticals Market Size, Share & Trends Analysis Report By Type of Biologic Lyophilized (Antibodies, Cell and Gene Therapies, Vaccines, Other Biologics), By Type of Primary Packaging System, By Region, And By Segment Forecasts, 2025-2034

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-06頁數 175報告編號 INSIGHTACE-a6965125bd

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

With a 2024 valuation of USD 984.1 Mn, the global Lyophilization Services for Biopharmaceuticals Market is forecasted to develop to USD 2861.4 Mn by 2034, demonstrating a CAGR of 11.4% during the 2025–2034 forecast window. Lyophilization Services for Biopharmaceuticals covers key industry insights & findings from the report: The mounting prevalence of meaningful chronic diseases, coupled with improving healthcare infrastructure in emerging markets, fuels the demand for. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. Market momentum is supported by mounting appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies. Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases. Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing. This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Lyophilization Services for Biopharmaceuticals Market Snapshot Chapter 4. Global Lyophilization Services for Biopharmaceuticals Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Biologic Lyophilized Types Estimates & Trend Analysis 5.1. By Biologic Lyophilized Types & Market Share, 2024 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Biologic Lyophilized Types: 5.2.1. Antibodies 5.2.2. Cell and Gene Therapies 5.2.3. Vaccines 5.2.4. Other Biologics Chapter 6. Market Segmentation 2: By Primary Packaging System Estimates & Trend Analysis 6.1. By Primary Packaging System & Market Share, 2024 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Primary Packaging System: 6.2.1. Vials 6.2.2. Syringes 6.2.3. Cartridges 6.2.4. Ampoules 6.2.5. Other Pakaging System Chapter 7. Lyophilization Services for Biopharmaceuticals Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) estimates and forecasts By Biologic Lyophilized Types, 2021-2034 7.1.3. North America Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) estimates and forecasts by Primary Packaging System, 2021-2034 7.1.4. North America Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 7.2. Europe 7.2.1. Europe Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) By Biologic Lyophilized Types, 2021-2034 7.2.3. Europe Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) estimates and forecasts by Primary Packaging System, 2021-2034 7.2.4. Europe Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) by country, 2021-2034 7.3. Asia Pacific 7.3.1. Asia Pacific Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) By Biologic Lyophilized Types, 2021-2034 7.3.3. Asia Pacific Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) estimates and forecasts by Primary Packaging System, 2021-2034 7.3.4. Asia Pacific Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) by country, 2021-2034 7.4. Latin America 7.4.1. Latin America Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) By Biologic Lyophilized Types, 2021-2034 7.4.3. Latin America Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) estimates and forecasts by Primary Packaging System, 2021-2034 7.4.4. Latin America Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) by country, 2021-2034 7.5. Middle East & Africa 7.5.1. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) By Biologic Lyophilized Types, 2021-2034 7.5.3. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) estimates and forecasts by Primary Packaging System, 2021-2034 7.5.4. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market revenue (US$ Million) by country, 2021-2034 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Baxter BioPharma Solutions 8.2.2. Curia 8.2.3. Emergent BioSolutions 8.2.4. LSNE Contract Manufacturing 8.2.5. Lyophilization Technology, Inc. 8.2.6. CordenPharma 8.2.7. Coriolis Pharma 8.2.8. Northway Biotech 8.2.9. ProJect Pharmaceutics 8.2.10. Vetter Pharma 8.2.11. BioZed Engineering 8.2.12. CinnaGen 8.2.13. MabPlex 8.2.14. Samsung Biologics 8.2.15. WuXi Biologics 8.2.16. Other Prominent Players

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們